Submitted by Anonymous (not verified) on 13 September 2023 - 15:33
Human medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Heart Failure, Date of authorisation: 26/05/2016, Revision: 18, Status: Authorised
Source: